Allonic
A software-controlled manufacturing platform that uses proprietary 3D Tissue Braiding to produce complex, bio-inspired, and compliant robotic bodies.
- CEO / Founder
- Benedek Tasi
- Team Size
- 11-50
- Stage
- Early-stage/Pilot (Recently closed a €6M pre-seed round to scale the team and manufacturing technology).
- Total Funding
- $7.2M
- Latest Round
- Pre-Seed ($7.2M, Feb 2025)
- Key Investors
- ["Visionaries Club","Day One Capital","OpenAI Angels","Hugging Face Angels","Prototype Capital","SDAC Ventures","TinyVC"]
Technology & Products
Key Products
["Automated 3D Tissue Braiding Platform","Software-Defined Robotic Body Design Suite","Bio-inspired Compliant Robotic Components (Limbs, Joints, and Tendon-driven systems)","Custom Multi-material Robotic Architectures"]
Technological Advantage
Combines info-bionics with additive manufacturing to create hardware that is inherently safe for human interaction and more resilient than traditional metal-and-bolt robotics.
Market & Competition
Target Customers
Humanoid robot developers, robotics OEMs, medical device manufacturers, and industrial automation companies requiring dexterous or human-safe hardware.
Industry Verticals
["Robotics & Humanoids","Advanced Manufacturing","Healthcare & Prosthetics","Aerospace & Defense"]
Competitors
["Clone Robotics","1X Technologies","Carbon"]